OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION is a Kit in the Human Prescription Drug category. It is labeled and distributed by Obagi Cosmeceuticals Llc. The primary component is .
| Product ID | 62032-535_9cd0dc6c-2478-4b07-892c-895098e5c81a |
| NDC | 62032-535 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION |
| Generic Name | Hydroquinone, Homosalate, Octisalate, And Zinc Oxide |
| Dosage Form | Kit |
| Marketing Start Date | 2019-12-02 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Obagi Cosmeceuticals LLC |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-12-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62032-518 | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION |
| 62032-524 | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION |
| 62032-532 | NU-DERM system NORMAL-DRY | Hydroquinone, Homosalate, Octisalate, and Zinc Oxide |
| 62032-531 | NU-DERM System NORMAL-Oily | HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE |
| 62032-533 | NU-DERM system NORMAL-oily | Hydroquinone, Homosalate, Octisalate, and Zinc Oxide |
| 62032-535 | OBAGI-C RX System NORMAL-DRY | HYDROQUINONE, HOMOSALATE, OCTISALATE, AND ZINC OXIDE |